These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 37547899)

  • 41. Reappraisal of [18F]FDG-PET/CT for diagnosis and management of cardiac implantable electronic device infections.
    Hernández-Meneses M; Perissinotti A; Páez-Martínez S; Llopis J; Dahl A; Sandoval E; Falces C; Ambrosioni J; Vidal B; Marco F; Cuervo G; Moreno A; Bosch J; Tolosana JM; Fuster D; Miró JM;
    Rev Esp Cardiol (Engl Ed); 2023 Dec; 76(12):970-979. PubMed ID: 37028797
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Trends of Cardiovascular Implantable Electronic Device Infection in 3 Decades: A Population-Based Study.
    Dai M; Cai C; Vaibhav V; Sohail MR; Hayes DL; Hodge DO; Tian Y; Asirvatham R; Cochuyt JJ; Huang C; Friedman PA; Cha YM
    JACC Clin Electrophysiol; 2019 Sep; 5(9):1071-1080. PubMed ID: 31537337
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cardiac implantable electronic device infections: the enemy that lurks beneath the skin.
    Margey R
    J Long Term Eff Med Implants; 2010; 20(3):203-17. PubMed ID: 21395519
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Causes and predictors of 30-day readmission after cardiovascular implantable electronic devices implantation: Insights from Nationwide Readmissions Database.
    Ahmad S; Munir MB; Sharbaugh MS; Althouse AD; Pasupula DK; Saba S
    J Cardiovasc Electrophysiol; 2018 Mar; 29(3):456-462. PubMed ID: 29193418
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Radiotherapy-Induced Malfunction in Contemporary Cardiovascular Implantable Electronic Devices: Clinical Incidence and Predictors.
    Grant JD; Jensen GL; Tang C; Pollard JM; Kry SF; Krishnan S; Dougherty AH; Gomez DR; Rozner MA
    JAMA Oncol; 2015 Aug; 1(5):624-32. PubMed ID: 26181143
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Infective Endocarditis Involving Implanted Cardiac Electronic Devices: JACC Focus Seminar 1/4.
    Chesdachai S; Esquer Garrigos Z; DeSimone CV; DeSimone DC; Baddour LM
    J Am Coll Cardiol; 2024 Apr; 83(14):1326-1337. PubMed ID: 38569763
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cardiac Implantable Electronic Device Therapy: Permanent Pacemakers, Implantable Cardioverter Defibrillators, and Cardiac Resynchronization Devices.
    Steffen MM; Osborn JS; Cutler MJ
    Med Clin North Am; 2019 Sep; 103(5):931-943. PubMed ID: 31378335
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Management of cardiac implantable electronic device infections: the challenges of understanding the scope of the problem and its associated mortality.
    Tarakji KG; Wilkoff BL
    Expert Rev Cardiovasc Ther; 2013 May; 11(5):607-16. PubMed ID: 23621142
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevention and Management of Cardiac Implantable Electronic Device Infections: State-of-the-Art and Future Directions.
    Mahtani K; Maclean E; Schilling RJ
    Heart Lung Circ; 2022 Nov; 31(11):1482-1492. PubMed ID: 35989213
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Low Utilization of Lead Extraction Among Patients With Infective Endocarditis and Implanted Cardiac Electronic Devices.
    Sciria CT; Kogan EV; Mandler AG; Yeo I; Simon MS; Kim LK; Ip JE; Liu CF; Markowitz SM; Lerman BB; Thomas G; Cheung JW
    J Am Coll Cardiol; 2023 May; 81(17):1714-1725. PubMed ID: 37100488
    [TBL] [Abstract][Full Text] [Related]  

  • 51. European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS).
    Blomström-Lundqvist C; Traykov V; Erba PA; Burri H; Nielsen JC; Bongiorni MG; Poole J; Boriani G; Costa R; Deharo JC; Epstein LM; Saghy L; Snygg-Martin U; Starck C; Tascini C; Strathmore N;
    Eur J Cardiothorac Surg; 2020 Jan; 57(1):e1-e31. PubMed ID: 31724720
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 16-year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States 1993 to 2008.
    Greenspon AJ; Patel JD; Lau E; Ochoa JA; Frisch DR; Ho RT; Pavri BB; Kurtz SM
    J Am Coll Cardiol; 2011 Aug; 58(10):1001-6. PubMed ID: 21867833
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of fibrotic capsule debridement during generator replacement on cardiac implantable electronic device infection risk.
    Goldenberg GR; Barsheshet A; Bishara J; Kadmon E; Omelchencko A; Strasberg B; Golovchiner G
    J Interv Card Electrophysiol; 2020 Jun; 58(1):113-118. PubMed ID: 31227978
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevention, Diagnosis, and Treatment of Cardiac Implantable Electronic Device Infections.
    Leung S; Danik S
    Curr Cardiol Rep; 2016 Jun; 18(6):58. PubMed ID: 27147510
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Device infections in implantable cardioverter defibrillators versus permanent pacemakers: A systematic review and meta-analysis.
    Rattanawong P; Kewcharoen J; Mekraksakit P; Mekritthikrai R; Prasitlumkum N; Vutthikraivit W; Putthapiban P; Dworkin J
    J Cardiovasc Electrophysiol; 2019 Jul; 30(7):1053-1065. PubMed ID: 30938929
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Infection of cardiac prosthetic valves and implantable electronic devices: early diagnosis and treatment.
    Lakkas L; Serim BD; Fotopoulos A; Iakovou I; Doumas A; Korkmaz U; Michalis LK; Sioka C
    Acta Cardiol; 2021 Aug; 76(6):569-575. PubMed ID: 32406333
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The cost of CIED infectious complications treatment in Poland from the perspective of Polish hospitals.
    Romanek J; Farkowski M; Bukowski H; Gołba K; Wita K; Mitkowski P; Przybylski A
    Kardiol Pol; 2022; 80(9):919-925. PubMed ID: 35698969
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Early Versus Delayed Lead Extraction in Patients With Infected Cardiovascular Implantable Electronic Devices.
    Lin AY; Saul T; Aldaas OM; Lupercio F; Ho G; Pollema T; Pretorius V; Birgersdotter-Green U
    JACC Clin Electrophysiol; 2021 Jun; 7(6):755-763. PubMed ID: 33358664
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In-hospital complications after implantation of cardiac implantable electronic devices: Analysis of a national inpatient database in Japan.
    Shakya S; Matsui H; Fushimi K; Yasunaga H
    J Cardiol; 2017 Nov; 70(5):405-410. PubMed ID: 28434707
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Frequency of permanent pacemaker or implantable cardioverter-defibrillator infection in patients with gram-negative bacteremia.
    Uslan DZ; Sohail MR; Friedman PA; Hayes DL; Wilson WR; Steckelberg JM; Baddour LM
    Clin Infect Dis; 2006 Sep; 43(6):731-6. PubMed ID: 16912947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.